Bioo Scientific

www.biooscientific.com

Bioo Scientific Corporation is an Austin, TX based biotechnology company that provides innovative solutions for food and feed safety testing, next generation sequencing (NGS) library prep and other life science research. Founded in 2003, Bioo Scientific’s novel technology is protected by current and pending patents worldwide.

Related News

MEDTECH, INDUSTRIAL IMPACT

QIAGEN AND HELIX PARTNER TO ADVANCE COMPANION DIAGNOSTICS FOR HEREDITARY DISEASES

QIAGEN | January 06, 2023

news image

QIAGEN recently announced an exclusive strategic partnership with Helix, a California population genomics leader, to advance companion diagnostics for hereditary diseases. The requirement for companion diagnostic devices and tests capable of detecting clinically relevant genetic abnormalities grows along with the accelerated development of precision medicines. These tests helps in making decisions by showing patients that are most likely to benefit from a specific therapeutic prod...

Read More

INDUSTRIAL IMPACT

XTALPI AND CK LIFE SCIENCES TO COLLABORATE IN AI-EMPOWERED TUMOUR VACCINE RESEARCH AND DEVELOPMENT, OPENING A NEW PARADIGM FOR SCIENTIFIC INNOVATION

XtalPi Inc. | November 25, 2022

news image

XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide. Accordin...

Read More

MEDTECH

HALO LABS LAUNCHES THE AURA GT™ FOR GENE THERAPY PRODUCT QUALITY

Halo Labs | October 05, 2021

news image

Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, Aura GT. Aura GT is part of the next generation in Halo Labs' popular family of instruments. Using Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM), Aura GT can distinguish aggregated capsids from contaminants, carrier proteins, and other particles that might adversely harm patients. Unique to Aura GT is...

Read More

YUFAN BIOTECHNOLOGIES AND ABOUND BIO SIGN MULTI-YEAR AGREEMENT TO DEVELOP NEXT GENERATION CAR T-CELL THERAPIES FOR CANCER

Yufan Biotechnologies | September 17, 2020

news image

Exhaustion of T-cells is a key reason why CAR T-cell therapy may fail to control cancer. Recent work led by Xuebin Liao, PhD, Professor of Pharmaceutical Science at Tsinghua University (Si et al., Cancer Cell 2020) shows that HPK1 (hematopoietic progenitor kinase 1) promotes T cell exhaustion via NFkB-Blimp1 activation and that blocking HPK1, either by gene knockout or by small-molecule inhibitors, is an attractive strategy to improve CAR T-cell immunotherapy. These innovative approaches a...

Read More
news image

MEDTECH, INDUSTRIAL IMPACT

QIAGEN AND HELIX PARTNER TO ADVANCE COMPANION DIAGNOSTICS FOR HEREDITARY DISEASES

QIAGEN | January 06, 2023

QIAGEN recently announced an exclusive strategic partnership with Helix, a California population genomics leader, to advance companion diagnostics for hereditary diseases. The requirement for companion diagnostic devices and tests capable of detecting clinically relevant genetic abnormalities grows along with the accelerated development of precision medicines. These tests helps in making decisions by showing patients that are most likely to benefit from a specific therapeutic prod...

Read More
news image

INDUSTRIAL IMPACT

XTALPI AND CK LIFE SCIENCES TO COLLABORATE IN AI-EMPOWERED TUMOUR VACCINE RESEARCH AND DEVELOPMENT, OPENING A NEW PARADIGM FOR SCIENTIFIC INNOVATION

XtalPi Inc. | November 25, 2022

XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide. Accordin...

Read More
news image

MEDTECH

HALO LABS LAUNCHES THE AURA GT™ FOR GENE THERAPY PRODUCT QUALITY

Halo Labs | October 05, 2021

Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, Aura GT. Aura GT is part of the next generation in Halo Labs' popular family of instruments. Using Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM), Aura GT can distinguish aggregated capsids from contaminants, carrier proteins, and other particles that might adversely harm patients. Unique to Aura GT is...

Read More
news image

YUFAN BIOTECHNOLOGIES AND ABOUND BIO SIGN MULTI-YEAR AGREEMENT TO DEVELOP NEXT GENERATION CAR T-CELL THERAPIES FOR CANCER

Yufan Biotechnologies | September 17, 2020

Exhaustion of T-cells is a key reason why CAR T-cell therapy may fail to control cancer. Recent work led by Xuebin Liao, PhD, Professor of Pharmaceutical Science at Tsinghua University (Si et al., Cancer Cell 2020) shows that HPK1 (hematopoietic progenitor kinase 1) promotes T cell exhaustion via NFkB-Blimp1 activation and that blocking HPK1, either by gene knockout or by small-molecule inhibitors, is an attractive strategy to improve CAR T-cell immunotherapy. These innovative approaches a...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us